Page 2 - Chronic Obstructive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Financial pressures, everyone are seeing higher prices.- can | financial pressures, everyone are . seeing higher prices.- can you seeing higher prices. hello? can you hear us? yes. _ seeing higher prices. hello? can you hear us? yes. i _ seeing higher prices. hello? can you hear us? yes, i can. _ seeing higher prices. hello? can you hear us? yes, i can. i _ seeing higher prices. hello? can you hear us? yes, i can. ijust_ seeing higher prices. hello? can you hear us? yes, i can. ijust wondered| hear us? yes, i can. i 'ust wondered how our hear us? yes, i can. i 'ust wondered howyourfindrng — ...

Regulatory approval for proof of pharmacology study for the first non-antibiotic macrolideREYKJAVIK, Iceland, August 31, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received...

First non-antibiotic macrolide to go into clinical development – targeting COPDSafety, tolerability and pharmacokinetic endpoints metPhase II planning underwayREYKJAVIK, Iceland, May 18, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modi...

REYKJAVIK, Iceland, March 24, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2022. EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment...

#ÚltimaHora|La Secretaría de Salud informó este viernes que en Morelos se han confirmado 42 mil 743 casos de covid-19; se han registrado cuatro mil 18...